Morningstar

Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients

EXETER, N.H., April 21, 2026 /PRNewswire/ -- Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and ...
MarketWatch

Vapotherm(R) Announces FDA 510(k) Clearance for the All Patient Circuit(TM), Enabling High Velocity Therapy for Neonatal to Adult Patients

The MarketWatch News Department was not involved in the creation of this content. EXETER, N.H., April 21, 2026 /PRNewswire/ -- Vapotherm, Inc., a developer and manufacturer of advanced respiratory ...